Page last updated: 2024-11-05

trifluoperazine and Colorectal Neoplasms

trifluoperazine has been researched along with Colorectal Neoplasms in 1 studies

Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Qian, K1
Sun, L1
Zhou, G1
Ge, H1
Meng, Y1
Li, J1
Li, X1
Fang, X1

Other Studies

1 other study available for trifluoperazine and Colorectal Neoplasms

ArticleYear
Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer.
    Journal of cellular biochemistry, 2019, Volume: 120, Issue:9

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival;

2019